The United States Alzheimer's Drugs Market is supported by substantial healthcare spending, a significant patient population, and strong research and development activities focused on innovative neurological treatments. Increasing adoption of disease-modifying therapies, symptomatic treatments, and personalized approaches is contributing to advances in Alzheimer's disease management. The...